SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIMONDI, Erika
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.648
AS - Asia 3.026
EU - Europa 1.752
SA - Sud America 492
AF - Africa 75
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 11.003
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.528
SG - Singapore 1.181
CN - Cina 707
IT - Italia 471
BR - Brasile 384
VN - Vietnam 347
DE - Germania 258
HK - Hong Kong 252
PL - Polonia 212
UA - Ucraina 178
GB - Regno Unito 173
TR - Turchia 134
FI - Finlandia 99
FR - Francia 83
JP - Giappone 81
RU - Federazione Russa 74
IN - India 73
ID - Indonesia 65
CA - Canada 60
SE - Svezia 54
BD - Bangladesh 42
AR - Argentina 41
MX - Messico 36
ZA - Sudafrica 33
IQ - Iraq 28
ES - Italia 27
NL - Olanda 27
BE - Belgio 20
VE - Venezuela 19
PK - Pakistan 18
CZ - Repubblica Ceca 15
EC - Ecuador 13
SA - Arabia Saudita 13
LT - Lituania 12
MY - Malesia 12
UZ - Uzbekistan 12
AT - Austria 11
CO - Colombia 11
AE - Emirati Arabi Uniti 9
KG - Kirghizistan 9
MA - Marocco 9
EG - Egitto 8
RO - Romania 8
CL - Cile 7
KE - Kenya 7
AU - Australia 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
JO - Giordania 6
AZ - Azerbaigian 5
IL - Israele 5
TN - Tunisia 5
UY - Uruguay 5
DZ - Algeria 4
JM - Giamaica 4
PH - Filippine 4
RS - Serbia 4
DK - Danimarca 3
HN - Honduras 3
HR - Croazia 3
IR - Iran 3
KR - Corea 3
PT - Portogallo 3
SN - Senegal 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GE - Georgia 2
GP - Guadalupe 2
GR - Grecia 2
IE - Irlanda 2
LB - Libano 2
LV - Lettonia 2
NP - Nepal 2
PE - Perù 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AQ - Antartide 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
DM - Dominica 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
KH - Cambogia 1
KZ - Kazakistan 1
ME - Montenegro 1
MM - Myanmar 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
Totale 10.996
Salva come PNG Salva come JPEG
Città #
Ashburn 717
Singapore 717
Fairfield 533
Woodbridge 487
San Jose 346
Houston 283
Beijing 252
Santa Clara 246
Hong Kong 244
Seattle 231
Chandler 218
Warsaw 209
Ann Arbor 203
Dallas 198
Wilmington 197
Jacksonville 190
Cambridge 187
Ferrara 186
Council Bluffs 131
Ho Chi Minh City 126
Los Angeles 102
New York 93
Munich 79
Hanoi 78
Tokyo 76
Izmir 64
Princeton 59
Lauterbourg 54
Jakarta 53
São Paulo 48
Nanjing 46
San Diego 42
Milan 40
Shanghai 37
Helsinki 36
Boardman 35
London 31
Montreal 26
Bologna 25
Orem 25
Buffalo 24
Denver 24
Chicago 22
Johannesburg 22
Chennai 21
Frankfurt am Main 20
Nanchang 20
Falls Church 19
Manchester 19
Brussels 17
Da Nang 17
Hefei 17
Tianjin 17
Boston 16
Mexico City 16
Shenyang 16
Turku 16
Atlanta 15
Dearborn 15
Dong Ket 15
Poplar 15
Rome 15
Brooklyn 14
Haiphong 14
The Dalles 14
Baghdad 13
Moscow 13
Rio de Janeiro 13
Toronto 13
Ankara 12
Nuremberg 12
Tashkent 12
Ferrara di Monte Baldo 11
Lappeenranta 11
San Francisco 11
Brno 10
Stockholm 10
Auburn Hills 9
Bishkek 9
Campinas 9
Hebei 9
Jiaxing 9
Mumbai 9
San Mateo 9
Bremen 8
Caracas 8
Changsha 8
Columbus 8
Falkenstein 8
Guangzhou 8
Norwalk 8
Riyadh 8
Secaucus 8
Zhengzhou 8
Dhaka 7
Hải Dương 7
Kunming 7
Mountain View 7
Nairobi 7
New Delhi 7
Totale 7.716
Salva come PNG Salva come JPEG
Nome #
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 272
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 271
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 265
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 250
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 247
miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment 242
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 234
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 226
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 223
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 214
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 212
Factors Predictive of Double Anterior Chamber Formation Following Deep Anterior Lamellar Keratoplasty 205
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 204
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions 201
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 200
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 200
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 197
A novel endovenous scaffold for the treatment of chronic venous obstruction in a porcine model: Histological and ultrastructural assessment 194
Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema 188
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 182
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 181
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 174
Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL 173
Human Colostrum and Breast Milk Contain High Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL). 172
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 172
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1 164
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 164
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota 163
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 162
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: recent advances 162
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 161
Lower maternal serum tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in early preeclampsia. A retrospective study 161
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 160
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 152
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 150
Role of vitamin D in the pathogenesis of atheromatosis 150
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 147
Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin: Letter to the editor 146
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 145
Human collecting lymphatic glycocalyx identification by electron microscopy and immunohistochemistry 141
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) 138
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 136
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 136
TRAIL Activates a Caspase 9/7-Dependent Pathway in Caspase 8/10-Defective SK-N-SH Neuroblastoma Cells with Two Functional End Points: Induction of Apoptosis and PGE2 Release 135
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 134
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 133
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 133
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions 130
Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Show a Long-term Stability in the Breast Milk of Mothers of Preterm Infants 129
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids 129
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 118
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study 116
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 111
MitoQ is able to modulate apoptosis and inflammation 99
Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts 98
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 94
null 92
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 91
null 90
null 90
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 90
null 88
Ultrastructural Alterations of Grafted Corneal Buttons: The Anatomic Basis for Stromal Peeling Along a Natural Plane of Separation 88
null 86
null 83
The role of the mTOR pathway in diabetic retinopathy 80
null 76
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 71
Tumor necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 70
null 69
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 61
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 59
null 55
NOVA2 expression in pituitary gland and in functioning and non-functioning pituitary adenomas: a preliminary study 54
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 44
null 44
null 42
Towards defining the chemical signature of inflammatory skin conditions: an in vitro model 27
Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide 21
TOWARDS DEFINING THE CHEMICAL SIGNATURE OF INFLAMMATORY SKIN CONDITIONS USING VOLATILE METABOLITES: AN IN VITRO MODEL 21
Totale 11.188
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.514
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.514
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021258 0 0 0 0 0 0 0 0 0 133 81 44
2021/2022615 28 54 25 21 56 48 56 37 21 55 60 154
2022/2023523 58 32 23 59 77 74 34 46 71 2 29 18
2023/2024375 33 39 13 12 20 57 16 41 1 23 16 104
2024/20251.604 42 30 132 90 210 126 56 83 306 146 218 165
2025/20264.586 463 283 421 560 693 301 581 284 463 537 0 0
Totale 11.188